Anixa Biosciences ANIX
NASDAQ ANIX
$3.71 +0.12 (+3.34%)
At close: Aug 21, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) Other Non Operating Income (2011 - 2017)

Anixa Biosciences' (ANIX) quarterly Other Non Operating Income came in at $2.8 million in Q4 2017, up 81.14% on a QoQ basis from $1.5 million in Q2 2017.

Anixa Biosciences (ANIX) Other Non Operating Income (2011 - 2017) Analysis & Trends

Anixa Biosciences (ANIX) has 4 years of Other Non Operating Income data on file, last reported at $2.8 million in Q4 2017.

  • Quarterly Other Non Operating Income changed N/A year-over-year to $2.8 million in Q4 2017, while the trailing twelve-month figure through Oct 2017 was $3.1 million (changed N/A YoY) and the FY2019 annual result came in at -$995000.0, up 17.5% from the prior year.
  • Other Non Operating Income advanced to $2.8 million in Q4 2017, from $1.5 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.8 million in Q4 2017 to a low of -$1.3 million in Q1 2014.
  • A 3-year average of $265996.9 and a median of $210000.0 in 2013 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 571.76% in 2014, down 571.76% in 2014.
  • Tracing ANIX's Other Non Operating Income over 3 years: stood at $210000.0 in 2013, then slumped by 689.68% to -$1.2 million in 2014, then soared by 326.39% to $2.8 million in 2017.
  • The last three Other Non Operating Income figures came in at $2.8 million (Q4 2017), $1.5 million (Q2 2017), and -$1.2 million (Q4 2014), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Anixa Biosciences 123.62 Mn 123.62 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2017 2.80 Mn
Apr 30, 2017 1.55 Mn
Oct 31, 2014 -1.24 Mn
Jul 31, 2014 850,000.00
Apr 30, 2014 -990,704.00
Jan 31, 2014 -1.32 Mn
Apr 30, 2013 210,000.00
Oct 31, 2011 -43,507.00
Jul 31, 2011 33,507.00